inōtiv Corporate Presentation June 2023
Long-Term Targets
Low- to Mid-
Double Digits
Mid-to-High-
Single Digits
High-Single
Digit to Low-
Double Digits
2x-3x
18% -22%
Preclinical
Revenue Growth
Research Models
Revenue Growth
Combined Organic
Revenue Growth
Adjusted EBITDA
Margin
19 |
Note: Adjusted EBITDA margin guidance is provided on a non-GAAP basis. The Company cannot
reconcile this guidance to target net income/loss margin without unreasonable effort because
certain items that impact net income/loss margin are out of the Company's control and/or
cannot be reasonably predicted at this time, which unavailable information could have a
significant impact on the Company's GAAP financial results.
Long-Term Net
Leverage Multiple
CORPORATE PRESENTATION
inōtiv
analyze, answer. advance.View entire presentation